Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms

被引:57
作者
Liu, Jie [1 ,3 ]
Shimizu, Kuniyoshi [1 ]
Tanaka, Akinobu [1 ]
Shinobu, Wakako [5 ]
Ohnuki, Koichiro [2 ]
Nakamura, Takanori [4 ]
Kondo, Ryuichiro [1 ]
机构
[1] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan
[2] Kyushu Nutr Welf Univ, Fac Food & Nutr, Kokurakita Ku, Kitakyushu, Fukuoka 8038511, Japan
[3] N Carolina State Univ, Coll Nat Resources, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA
[4] Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[5] Nihon Dempa Kogyo Co Ltd, Chitose, Hokkaido 0660009, Japan
关键词
NATURAL-PRODUCTS; LUCIDUM; TUBULIN;
D O I
10.1038/srep00905
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ganoderma fungus (Ganodermataceae) is a multifunctional medicinal mushroom and has been traditionally used for the treatment of various types of disease. Ganoderic acid DM (1) is a representative triterpenoid isolated from G. lingzhi and exhibits various biological activities. However, a universal starting point that triggers multiple signaling pathways and results in multifunctionality of 1 is unknown. Here we demonstrate the important clues regarding the mechanisms underlying multi-medicinal action of 1. We examined structure-activity relationships between 1 and its analogs and found that the carbonyl group at C-3 was essential for cytotoxicity. Subsequently, we used 1-conjugated magnetic beads as a probe and identified tubulin as a specific 1-binding protein. Furthermore, 1 showed a similar Kd to that of vinblastine and also affected assembly of tubulin polymers. This study revealed multiple biological activities of 1 and may contribute to the design and development of new tubulin-inhibiting agents.
引用
收藏
页数:5
相关论文
共 23 条
[1]  
BONNE D, 1985, J BIOL CHEM, V260, P2819
[2]   Species clarification of the prize medicinal Ganoderma mushroom "Lingzhi" [J].
Cao, Yun ;
Wu, Sheng-Hua ;
Dai, Yu-Cheng .
FUNGAL DIVERSITY, 2012, 56 (01) :49-62
[3]   Medicinal mushrooms in prevention and control of diabetes mellitus [J].
De Silva, Dilani D. ;
Rapior, Sylvie ;
Hyde, Kevin D. ;
Bahkali, Ali H. .
FUNGAL DIVERSITY, 2012, 56 (01) :1-29
[4]   Synergie between molecular imprinted polymer based on solid-phase extraction and quartz crystal microbalance technique for 8-OHdG sensing [J].
Ersoz, Arzu ;
Diltemiz, S. Emir ;
Ozcan, A. Atilir ;
Denizli, Adil ;
Say, Ridvan .
BIOSENSORS & BIOELECTRONICS, 2008, 24 (04) :742-747
[5]   Anti-androgenic activities of Ganoderma lucidum [J].
Fujita, R ;
Liu, J ;
Shimizu, K ;
Konishi, F ;
Noda, K ;
Kumamoto, S ;
Ueda, C ;
Tajiri, H ;
Kaneko, S ;
Suimi, Y ;
Kondo, R .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 102 (01) :107-112
[6]   Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation [J].
Iwatsuki, K ;
Akihisa, T ;
Tokuda, H ;
Ukiya, M ;
Oshikubo, M ;
Kimura, Y ;
Asano, T ;
Nomura, A ;
Nishino, H .
JOURNAL OF NATURAL PRODUCTS, 2003, 66 (12) :1582-1585
[7]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[8]   Tubulin-Interactive Natural Products as Anticancer Agents [J].
Kingston, David G. I. .
JOURNAL OF NATURAL PRODUCTS, 2009, 72 (03) :507-515
[9]  
KOHDA H, 1985, CHEM PHARM BULL, V33, P1367
[10]  
KOMODA Y, 1989, CHEM PHARM BULL, V37, P531